PLOD1 and prostate carcinoma: We subsequently validated the expression differences of risk genes in prostatic epithelial cells (PrEC LH) and a panel of prostate cancer cell lines (VCaP, MDA PCa 2b, DU145, LNCaP, 22Rv1, PC-3, NCI-H660) using the CCLE database (Figure 10A).